The effects of cognition, quality of life, and fatigue on olfactory function in patients with multiple sclerosis

MakaleAçık ErişimScopus SJRQ2
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Aim: The frequency of olfactory dysfunction in patients with Multiple Sclerosis (MS) has revealed very different results in studies. Some studies have shown that olfactory dysfunction may be associated with cognitive impairment and poor quality of life. In these studies, different odor tests and cognitive tests were used and different results were obtained. Materials and methods: Forty literate patients over the age of 18 and 24 healthy volunteers of similar age and education were included in the study. Sniffin' Sticks Odor Test, California Verbal Learning Test II, Symbol Digit Modalities Test, Revised Brief Visuospatial Memory Test, Trail-Making Test, Quality of Life Short Form-36, Fatigue Impact Scale, Beck Depression Inventory, and Beck Anxiety Inventory were applied to the individuals. Results: Olfactory dysfunction was detected in 50 % of the patients. High disability rate, low cognitive functions, low quality of life, and fatigue were identified as the factors affecting olfactory function negatively. Odor discrimination and identification abilities were associated with disability level and cognitive functions, whereas quality of life was linked to odor threshold scores. The olfactory function and cognitive abilities of patients with progressive MS (n = 5) were worse than those of patients with relapsing remitting MS (n = 35). Conclusion: Olfactory dysfunction is common in patients with MS and is associated with disability and quality of life. Olfactory function can be used in the follow-up of patients and olfactory dysfunction deserves further study as a metric that might emerge as a biomarker.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/kostu/10591Resmi atıflarda kullanılan kalıcı adres
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
1
WoS
1
OpenAlex
1
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAcikgoz, Mustafa
dc.contributor.authorPiri Cinar, Bilge
dc.contributor.authorAciman Demirel, Esra
dc.contributor.authorCelebi, Ulufer
dc.contributor.authorCekic, Sibel
dc.contributor.authorElicora, Sultan
dc.contributor.authorAtasoy, Hüseyin Tugrul
dc.date.accessioned2026-10-27T23:47:39.881587301Z
dc.date.available2026-10-27T23:47:39.881587301Z
dc.date.issued2023
dc.description.abstractAim: The frequency of olfactory dysfunction in patients with Multiple Sclerosis (MS) has revealed very different results in studies. Some studies have shown that olfactory dysfunction may be associated with cognitive impairment and poor quality of life. In these studies, different odor tests and cognitive tests were used and different results were obtained. Materials and methods: Forty literate patients over the age of 18 and 24 healthy volunteers of similar age and education were included in the study. Sniffin' Sticks Odor Test, California Verbal Learning Test II, Symbol Digit Modalities Test, Revised Brief Visuospatial Memory Test, Trail-Making Test, Quality of Life Short Form-36, Fatigue Impact Scale, Beck Depression Inventory, and Beck Anxiety Inventory were applied to the individuals. Results: Olfactory dysfunction was detected in 50 % of the patients. High disability rate, low cognitive functions, low quality of life, and fatigue were identified as the factors affecting olfactory function negatively. Odor discrimination and identification abilities were associated with disability level and cognitive functions, whereas quality of life was linked to odor threshold scores. The olfactory function and cognitive abilities of patients with progressive MS (n = 5) were worse than those of patients with relapsing remitting MS (n = 35). Conclusion: Olfactory dysfunction is common in patients with MS and is associated with disability and quality of life. Olfactory function can be used in the follow-up of patients and olfactory dysfunction deserves further study as a metric that might emerge as a biomarker.
dc.identifier.articlenumber107739
dc.identifier.doi10.1016/j.clineuro.2023.107739
dc.identifier.eissn1872-6968
dc.identifier.issn0303-8467
dc.identifier.pmid37146370
dc.identifier.scopus2-s2.0-85154579934
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/kostu/10591
dc.identifier.volume229
dc.identifier.wosWOS:000998456700001
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofClinical Neurology and Neurosurgery
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCognition
dc.subjectDisability
dc.subjectMultiple sclerosis
dc.subjectOlfactory dysfunction
dc.subjectQuality of life
dc.subject.classificationClinical Neurology
dc.subject.classificationSurgery
dc.subject.classificationNeurosciences & Neurology
dc.subject.otherAdult
dc.subject.otherCognition
dc.subject.otherFatigue
dc.subject.otherHumans
dc.subject.otherMiddle Aged
dc.subject.otherMultiple Sclerosis
dc.subject.otherOlfaction Disorders
dc.subject.otherQuality of Life
dc.subject.otherbeta1a interferon
dc.subject.otherbeta1b interferon
dc.subject.otherdimethyl fumarate
dc.subject.otherfingolimod
dc.subject.otherglatiramer
dc.subject.othernatalizumab
dc.subject.otherocrelizumab
dc.subject.otherteriflunomide
dc.subject.otheranxiety
dc.subject.otherArticle
dc.subject.otherBeck Anxiety Inventory
dc.subject.otherBeck Depression Inventory
dc.subject.otherCalifornia verbal learning test
dc.subject.otherclinical article
dc.subject.othercognitive defect
dc.subject.othercomparative study
dc.subject.othercontrolled study
dc.subject.otherdepression
dc.subject.otherdisability
dc.subject.otherdisease duration
dc.subject.otherdisease exacerbation
dc.subject.othereducational status
dc.subject.otherFatigue Impact Scale
dc.subject.otherfemale
dc.subject.otherfollow up
dc.subject.otherhuman
dc.subject.othermale
dc.subject.othermemory test
dc.subject.othermental health
dc.subject.otherolfactory discrimination
dc.subject.otherprogressive multiple sclerosis
dc.subject.otherrelapse
dc.subject.otherrelapsing remitting multiple sclerosis
dc.subject.otherShort Form 36
dc.subject.othersmelling
dc.subject.othersmelling disorder
dc.subject.othersocial interaction
dc.subject.othersymbol digit modalities test
dc.subject.othertrail making test
dc.subject.othercomplication
dc.titleThe effects of cognition, quality of life, and fatigue on olfactory function in patients with multiple sclerosis
dc.typeArticle
rdl.citation.openalex1
rdl.citation.scopus1
rdl.citation.wos1
rdl.departmentDepartment of Neurology, Faculty of Medicine, Zonguldak Bulent Ecevit University, Zonguldak, Turkey
rdl.departmentDepartment of Neurology, Bursa Dr. Ayten Bozkaya Spastic Children's Hospital and Rehabilitation Center, Bursa, Turkey
rdl.departmentDepartment of Otorhinolaryngology, Kocaeli Health and Technology University, Kocaeli, Turkey
rdl.oa.statusgreen
rdl.oa.statuspreprint
rdl.oa.urlhttps://hdl.handle.net/20.500.12628/27911
rdl.scopus.quartileQ2
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)